What does CUSIP 00972D105 represent in this 13F holders report?

CUSIP 00972D105 is the security identifier for AKBA - Akebia Therapeutics, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held AKBA - Akebia Therapeutics, Inc. - COMMON STOCK in Q1 2019?

165 institutional investors reported AKBA - Akebia Therapeutics, Inc. - COMMON STOCK for Q1 2019. Use the holders table for investor-level position and value details.

Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)

CUSIP: 00972D105

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / COMMON STOCK
Shares outstanding: 270,093,163
Total 13F shares: 84,729,878
Share change: +3,693,495
Total reported value: $693,928,655
Put/Call ratio: 47%
Price per share: $8.19
Number of holders: 165
Value change: +$34,225,709
Number of buys: 72
Number of sells: 74

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2019
Previous quarter: Q4 2018

Recent filing periods for CUSIP 00972D105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAUPOST GROUP LLC/MA	13F	Company	9.1%	24,471,453	$135,327,000	—	31 Dec 2018	13F
BlackRock Finance, Inc.	13F	Company	3.1%	8,296,503	$45,881,000	—	31 Dec 2018	13F
ABRAMS CAPITAL MANAGEMENT, L.P.	13F	Company	2.1%	5,656,462	$31,280,000	—	31 Dec 2018	13F
Nantahala Capital Management, LLC	13F	Company	1.9%	5,064,089	$28,004,000	—	31 Dec 2018	13F
VANGUARD GROUP INC	13F	Company	1.8%	4,907,351	$27,138,000	—	31 Dec 2018	13F
Novo Holdings A/S	13F	Company	1.1%	3,100,000	$17,143,000	—	31 Dec 2018	13F
STATE STREET CORP	13F	Company	0.98%	2,637,846	$14,587,000	—	31 Dec 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.63%	1,703,440	$9,182,000	—	31 Dec 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.53%	1,439,742	$7,961,000	—	31 Dec 2018	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.45%	1,221,498	$6,755,000	—	31 Dec 2018	13F
Clearbridge Investments, LLC	13F	Company	0.45%	1,215,886	$6,724,000	—	31 Dec 2018	13F
Rubric Capital Management LP	13F	Company	0.4%	1,070,095	$5,918,000	—	31 Dec 2018	13F
NORTHERN TRUST CORP	13F	Company	0.39%	1,065,381	$5,892,000	—	31 Dec 2018	13F
MORGAN STANLEY	13F	Company	0.38%	1,033,908	$5,717,000	—	31 Dec 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.37%	1,011,544	$5,593,000	—	31 Dec 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.35%	942,599	$5,212,000	—	31 Dec 2018	13F
DAFNA Capital Management LLC	13F	Company	0.26%	715,538	$3,957,000	—	31 Dec 2018	13F
NORGES BANK	13F	Company	0.23%	632,459	$3,497,000	—	31 Dec 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.21%	560,260	$3,099,000	—	31 Dec 2018	13F
Bank of New York Mellon Corp	13F	Company	0.2%	548,595	$3,034,000	—	31 Dec 2018	13F
PKO Investment Management Joint-Stock Co	13F	Company	0.2%	548,376	$3,032,519	—	31 Dec 2018	13F
MARSHALL WACE, LLP	13F	Company	0.2%	533,941	$2,953,000	—	31 Dec 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.19%	514,080	$2,843,000	—	31 Dec 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.19%	504,373	$2,789,000	—	31 Dec 2018	13F
Spark Investment Management LLC	13F	Company	0.18%	488,500	$2,701,000	—	31 Dec 2018	13F
Artal Group S.A.	13F	Company	0.18%	475,000	$2,627,000	—	31 Dec 2018	13F
Old West Investment Management, LLC	13F	Company	0.17%	459,457	$2,540,000	—	31 Dec 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.15%	417,178	$2,307,000	—	31 Dec 2018	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.15%	414,852	$2,294,000	—	31 Dec 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.15%	409,908	$2,267,000	—	31 Dec 2018	13F
Man Group plc	13F	Company	0.15%	397,804	$2,200,000	—	31 Dec 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.14%	368,503	$2,037,000	—	31 Dec 2018	13F
Stanley-Laman Group, Ltd.	13F	Company	0.12%	334,328	$1,849,000	—	31 Dec 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.12%	330,979	$1,830,000	—	31 Dec 2018	13F
S.c.a. Candriam	13F	Individual	0.11%	300,000	$1,659,000	—	31 Dec 2018	13F
CITIGROUP INC	13F	Company	0.11%	297,505	$1,645,000	—	31 Dec 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.1%	281,328	$1,555,000	—	31 Dec 2018	13F
Boston Partners	13F	Company	0.1%	279,378	$1,545,000	—	31 Dec 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.1%	277,050	$1,532,000	—	31 Dec 2018	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.1%	260,200	$1,438,000	—	31 Dec 2018	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.09%	249,469	$1,380,000	—	31 Dec 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.09%	237,527	$1,314,000	—	31 Dec 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	221,526	$1,225,000	—	31 Dec 2018	13F
ALPS ADVISORS INC	13F	Company	0.08%	220,395	$1,219,000	—	31 Dec 2018	13F
FMR LLC	13F	Company	0.08%	214,168	$1,184,000	—	31 Dec 2018	13F
Tekla Capital Management LLC	13F	Company	0.08%	213,942	$1,183,000	—	31 Dec 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.08%	208,090	$1,151,000	—	31 Dec 2018	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.07%	192,801	$1,066,000	—	31 Dec 2018	13F
UBS Group AG	13F	Company	0.07%	184,153	$1,019,000	—	31 Dec 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.06%	173,269	$958,000	—	31 Dec 2018	13F

Institutional Holders of Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) as of Q1 2019

As of 31 Mar 2019, Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) was held by 165 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 84,729,878 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BlackRock Inc., VANGUARD GROUP INC, ABRAMS CAPITAL MANAGEMENT, L.P., Nantahala Capital Management, LLC, STATE STREET CORP, Novo Holdings A/S, PERCEPTIVE ADVISORS LLC, RICE HALL JAMES & ASSOCIATES, LLC, and Consonance Capital Management LP. This page lists 165 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders

154

Q1 2019 holders

165

Holder diff

Investor	Q4 2018 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q4 2018 Value $	Q1 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.